Overall Survival and Progression-Free Survival of Patients Following Luspatercept Treatment in the MEDALIST Trial

被引:2
|
作者
Santini, Valeria [1 ]
Fenaux, Pierre [2 ]
Zeidan, Amer M. [3 ,4 ]
Komrokji, Rami S. [5 ]
Buckstein, Rena [6 ]
Oliva, Esther Natalie [7 ]
Ha, Xianwei [8 ]
Miteva, Dimana [9 ]
Yucel, Aylin [8 ]
Nadal, Jose Alberto [9 ]
Platzbecker, Uwe [10 ]
机构
[1] Univ Florence, Florence, Italy
[2] Hop St Louis, Assistance Publ Hop Paris AP HP, Paris, France
[3] Yale Univ, Yale Sch Med, New Haven, CT USA
[4] Yale Univ, Yale Canc Ctr, New Haven, CT USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[6] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[7] Grande Osped Metropolitano Bianchi Melacrino More, Reggio Di Calabria, Italy
[8] Bristol Myers Squibb, Princeton, NJ USA
[9] Bristol Myers Squibb Co, Celgene Int Sarl, Boudry, Switzerland
[10] Univ Leipzig, Med Ctr, Dept Hematol Cell Therapy & Hemostaseol, Leipzig, Germany
关键词
D O I
10.1182/blood-2022-157489
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4079 / 4081
页数:3
相关论文
共 50 条
  • [21] Progression-Free Survival as a Surrogate Endpoint of Overall Survival in Patients With Metastatic Renal Cell Carcinoma
    Halabi, Susan
    Rini, Brian
    Escudier, Bernard
    Stadler, Walter M.
    Small, Eric J.
    CANCER, 2014, 120 (01) : 52 - 60
  • [22] Progression-free survival as a surrogate endpoint for overall survival in patients with relapsed or refractory multiple myeloma
    Dimopoulos, Meletios
    Sonneveld, Pieter
    Manier, Salomon
    Lam, Annette
    Roccia, Tito
    Schecter, Jordan M.
    Cost, Patricia
    Pacaud, Lida
    Poirier, Abbey
    Tremblay, Gabriel
    Lan, Tommy
    Valluri, Satish
    Kumar, Shaji
    BMC CANCER, 2024, 24 (01)
  • [23] Progression-free survival and overall survival of pembrolizumab for patients with esophageal cancer: a meta-analysis
    Kurniawan, A.
    Wijovi, F.
    Angel, P.
    Priantono, D.
    Sari, C.
    Amelia, D. Astri Rivera
    Djatnika, D.
    Nasution, M. Arman
    Purlikasari, N. Prasasti
    Ariyanti, F.
    Wisman, B. Agustia
    Kurniawan, R.
    Sinurat, J.
    Ardian, A.
    Sugianto, G. Chandra Kirana
    Siregar, N. Novianti
    Dewi, N. Merlynda P.
    ANNALS OF ONCOLOGY, 2024, 35 : S1365 - S1365
  • [24] Soluble MICA as a prognostic factor for the overall survival and progression-free survival of multiple myeloma patients
    Rebmann, V.
    Schuett, P.
    Brandhorst, D.
    Opalka, B.
    Nowrousian, M. R.
    Moritz, T.
    Grosse-Wilde, H.
    TISSUE ANTIGENS, 2007, 69 (05): : 390 - 390
  • [25] Association of Progression-Free Survival With Overall Survival in Patients With Neuroendocrine Tumor Treated With Somatostatin Analogs
    Ter-Minassian, Monica
    Brooks, Nichole V.
    Brais, Lauren K.
    Chan, Jennifer A.
    Christiani, David C.
    Lin, Xihong
    Gabriel, Sylvie
    Dinet, Jerome
    Kulke, Matthew H.
    PANCREAS, 2016, 45 (03) : 483 - 483
  • [26] Effects of combined sintilimab and chemotherapy on progression-free survival and overall survival in osteosarcoma patients with metastasis
    Li, Fan
    Zhang, De-bao
    Ma, Yue
    Song, Yang
    Duan, Xian-liang
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (04) : 648 - 651
  • [27] Progression-free survival and overall survival of pembrolizumab for patients with esophageal cancer: a meta-analysis
    Santoso, K. Aurelia
    Kosayuz, S.
    Atmaja, W. Surya
    Amalia, A. Irviani Ukhti
    Subroto, D. Ravinder Theodeus
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1365 - S1365
  • [28] PREDICTORS OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN IDH1-MUTANT GLIOMA PATIENTS
    Loebel, Franziska
    Curry, William T.
    Barker, Fred G.
    Lelic, Nina
    Chi, Andrew S.
    Cahill, Daniel P.
    NEURO-ONCOLOGY, 2013, 15 : 146 - 146
  • [29] PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Dimopoulos, M.
    Sonneveld, P.
    Nahi, H.
    Kumar, S.
    Hashim, M.
    Kulakova, M.
    Duran, M.
    Heeg, B.
    Lam, A.
    Dearden, L.
    VALUE IN HEALTH, 2017, 20 (09) : A408 - A408
  • [30] Comprehensive geriatric assessment in elderly cancer patients: Impact on overall survival and progression-free survival
    Chen, H
    Overcash, J
    Extermann, M
    Canter, A
    Balducci, L
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S30 - S30